CAMBRIDGE, Mass., May 31, 2025 (GLOBE NEWSWIRE) -- Harbinger Health, a biotechnology company pioneering the detection of early cancer, today announced clinical data demonstrating the performance of ...

Association between wildfire-dominated PM2.5 exposure and non-small cell lung cancer survival in California. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...

The Multi-Cancer Early Detection (MCED) Market is witnessing an unprecedented surge as diagnostic technologies evolve beyond traditional organ-specific screening to comprehensive, minimally invasive ...

The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period. This growth is primarily due to the rising awareness and increasing demand for ...

Using a single blood sample, multi-cancer early detection (MCED) tests screen for numerous types of cancers, including breast, ovarian, colorectal, pancreatic and prostate cancers. Trials are underway ...

Multicancer early detection (MCED) assays use circulating tumor DNA, methylation patterns, RNA, and protein biomarkers to detect multiple cancer types early, potentially revolutionizing cancer ...

The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...

Dublin, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The "Multi Cancer Early Detection Market and Forecasts 2025-2033" report has been added to ResearchAndMarkets.com's offering. The global multi cancer early ...

Grey’s Anatomy star Kate Walsh called this decision a “no brainer” in both a serious and punny way. It’s her decision to team up with the company GRAIL to advocate for more multi-cancer early ...